Treatment type: Microbiome medicine

Taking lessons learned studying coral reefs, a Melbourne researcher is taking a plunge into the microorganisms that inhabit our insides.…  Read more

Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.…  Read more

This discovery of the potential therapeutic benefits of a naturally occurring compound found in broccoli has earned two scientists a prestigious $10 000 award to progress their preeclampsia research.…  Read more

Crohn’s is an inflammatory disease which affects the gastrointestinal tract. It is incurable and usually chronic with periods of flare ups lasting from anywhere from a few days to a several months.…  Read more

Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.…  Read more

The discovery that the bladder isn’t sterile has opened up new avenues of treatment for urinary tract infections (UTI).…  Read more

New and improved treatments for many serious ailments could follow a prestigious $5 million NHMRC Synergy grant to a team led by Hudson Institute of Medical Research scientists.…  Read more

Volunteers are needed for a research project looking at whether the composition of the gut microbiome changes across the menstrual cycle.…  Read more

The introduction of faecal transplants has provided a new and welcome approach to treating difficult bacterial infections. However, following a patient death, there are questions over their future use. How can the risks surrounding transplants be removed to reap the benefits of this promising therapeutic treatment?…  Read more